MannKind Corporation Stock News

Dr. Laura Heisler is hoping a new round of funding for the Payroll Protection Program will provide a lifeline to keep her practice afloat.

The April 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.

New guidance suggests that public companies will have a difficult time getting a share of the $320 billion in new Paycheck Protection Program funds.

Following objections over large publicly traded companies getting forgivable loans under the Payroll Protection Program, the U.S. Treasury issues new guidance explaining that the program is meant for

Some businesses seeking coronavirus loans got to avoid flaky online portals or backed-up queues. Many other small businesses couldn’t get their loan requests submitted before the money dried up

MannKind Co. (NASDAQ:MNKD) has received an average rating of “Buy” from the eight research firms that are covering the firm, MarketBeat Ratings reports. Three analysts have rated the stock with a

Even with the U.S. Senate set to vote later today on passing an additional relief bill for small businesses in the U.S., there is a bright spotlight being thrown on where the funds from the original

Wall Street analysts expect MannKind Co. (NASDAQ:MNKD) to announce ($0.06) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for M

MannKind (NASDAQ:MNKD) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Saturday, Zacks.com reports. The brokerage currently ha

MannKind Corporation (MNKD) today announced that it received a loan of approximately $4.9 million from JPMorgan Chase Bank, N.A., as lender, pursuant to the Paycheck Protection Program (“PPP”) of

The March 31 short interest data has been compared with the previous report, and short interest in these selected biotech stocks shrank.

Raymond James & Associates lifted its position in MannKind Co. (NASDAQ:MNKD) by 4.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission

VIVUS (NASDAQ:VVUS) -48% after announcing $11.6M direct offering.SG Blocks (NASDAQ:SGBX) -38% after pricing equity offering.Immunomedics (NASDAQ:IMMU) -19%.BlackBerry (NYSE:BB) -17% on Q4 earnin